Cellectar Biosciences Inc (CLRB)
3.06
-0.05
(-1.61%)
USD |
NASDAQ |
Apr 24, 16:00
3.055
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Gross Profit (TTM)
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.0083M |
| September 30, 2010 | 0.0277M |
| June 30, 2010 | 0.0414M |
| March 31, 2010 | 0.0737M |
| December 31, 2009 | 0.0963M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Perspective Therapeutics Inc | -- |
| Eli Lilly and Co | 27.04B |
| Actinium Pharmaceuticals Inc | -- |
| Bristol-Myers Squibb Co | 34.31B |
| Altimmune Inc | -- |